Literature DB >> 31493474

Angiographic contrast mechanism comparison between Simultaneous Non-contrast Angiography and intraPlaque hemorrhage (SNAP) sequence and Time of Flight (TOF) sequence for intracranial artery.

Qiang Zhang1, Zhensen Chen2, Shuo Chen1, Xinke Liu3, Jia Ning1, Yongjun Han4, Li Chen2, Le He1, Xihai Zhao1, Yuhui Xiong1, Hua Guo1, Chun Yuan2, Rui Li5, Huijun Chen6.   

Abstract

PURPOSE: To theoretically compare the MR angiography (MRA) contrast mechanism of Time of Flight (TOF) and Simultaneous Non-contrast Angiography and intraPlaque hemorrhage (SNAP) for intracranial artery imaging with in-vivo validation.
METHODS: The contrast ratio (CR) of SNAP and TOF was simulated under different blood velocities and travel distance that the blood had flown through. The CR and the slope of CR with respect to blood velocity of SNAP and TOF were compared in theoretical simulation. Two healthy subjects (a 60 years old female and a 29 years old male) were imaged on a 3 T MR scanner with SNAP, TOF and phase contrast (PC) images as the validation set. The measured CR from the images in validation set was compared with the theoretically simulated CR by Person's correlation coefficient. The ratio of CR difference to velocity difference in the validation set was compared between TOF and SNAP with Student's t-test. Thirty patients (21 males, age: 48 ± 13.8 years) with carotid artery atherosclerotic plaque were imaged with both TOF and SNAP as the comparison test. Between TOF and SNAP, the CR and total artery length were compared with Student's t-test, and the prevalence of stenosis was compared with Cohen's kappa in comparison test.
RESULTS: The theoretically simulated CR was significantly correlated with in-vivo measured CR from the validation set for TOF (p < 0.001) and SNAP (p < 0.001). The simulation revealed that the CR of SNAP was higher than that of TOF when the blood velocity and travel distance were within the range to have effective MRA contrast. Similarly, the in-vivo comparison test showed that SNAP had higher CR (p < 0.001 for all tested intracranial arteries) and longer total artery length (1.4 ± 0.4 m vs 1.2 ± 0.2 m, p < 0.001) than TOF. The stenosis detection performance was similar between TOF and SNAP (Cohen's kappa 0.72; 95% confidence interval: 0.51-0.93). Moreover, compared with TOF, SNAP showed higher slope of CR with respect to velocity in simulation (0.06 ± 0.02 s/cm vs 0.02 ± 0.05 s/cm, p < 0.001), and higher ratio of CR difference to velocity difference in validation test (0.47 ± 0.38 s/cm vs 0.19 ± 0.38 s/cm, p = 0.001).
CONCLUSIONS: Compared with TOF, the SNAP shows better performance to visualize distal intracranial artery and worse performance to visualize ICA, and is more sensitive to blood velocity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood velocity; MRA contrast mechanism; SNAP; TOF

Mesh:

Year:  2019        PMID: 31493474     DOI: 10.1016/j.mri.2019.09.001

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  3 in total

1.  Associations of intracranial artery length and branch number on non-contrast enhanced MRA with cognitive impairment in individuals with carotid atherosclerosis.

Authors:  Zhensen Chen; Anders Gould; Duygu Baylam Geleri; Niranjan Balu; Li Chen; Baocheng Chu; Kristi Pimentel; Gador Canton; Thomas S Hatsukami; Chun Yuan
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

2.  Vessel length on SNAP MRA and TOF MRA is a potential imaging biomarker for brain blood flow.

Authors:  Anders Gould; Zhensen Chen; Duygu Baylam Geleri; Niranjan Balu; Zechen Zhou; Li Chen; Baocheng Chu; Kristi Pimentel; Gador Canton; Thomas Hatsukami; Chun Yuan
Journal:  Magn Reson Imaging       Date:  2021-03-06       Impact factor: 3.130

3.  Characteristics of Symptomatic Basilar Artery Stenosis Using High-Resolution Magnetic Resonance Imaging in Ischemic Stroke Patients.

Authors:  Hyun Goo Kang; Chan-Hyuk Lee; Byoung-Soo Shin; Gyung Ho Chung; Hyo Sung Kwak
Journal:  J Atheroscler Thromb       Date:  2020-11-15       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.